BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 3095928)

  • 21. Expression of normal myeloid-associated antigens by acute leukemia cells.
    Dinndorf PA; Andrews RG; Benjamin D; Ridgway D; Wolff L; Bernstein ID
    Blood; 1986 Apr; 67(4):1048-53. PubMed ID: 2937468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell differentiation stages identified by molecular and immunologic analysis of the T cell receptor complex in childhood lymphoblastic leukemia.
    Mirro J; Kitchingman G; Behm FG; Murphy SB; Goorha RM
    Blood; 1987 Mar; 69(3):908-12. PubMed ID: 3101767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytologic, immunologic, and clinical diversity in non-Hodgkin's lymphoma: therapeutic implications.
    Urba WJ; Longo DL
    Semin Oncol; 1985 Sep; 12(3):250-67. PubMed ID: 3931224
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular aspects of immunoglobulin expression by human B cell leukemias and lymphomas.
    Gordon J
    Adv Cancer Res; 1984; 41():71-154. PubMed ID: 6428177
    [No Abstract]   [Full Text] [Related]  

  • 25. Undifferentiated leukemia of infancy with t(11:17) chromosomal rearrangement. Coexpressing myeloid and B cell restricted antigens.
    Umiel T; Nadler LM; Cohen IJ; Levine H; Stark B; Mammon Z; Dzaldetti M; Rechavi G; Simoni F; Katzir N
    Cancer; 1987 Mar; 59(6):1143-9. PubMed ID: 3102033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Classification of acute leukemias by surface markers and correlation with the morphological diagnosis. Results of 111 cases].
    von Fliedner V; Carrel S; Morell A; Heumann D; Losa G; Hirt A; Jeannet M; Mach JP; Cruchaud A
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1524-6. PubMed ID: 6975992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
    Nadler LM; Ritz J; Hardy R; Pesando JM; Schlossman SF; Stashenko P
    J Clin Invest; 1981 Jan; 67(1):134-40. PubMed ID: 6969730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance.
    Mirro J; Zipf TF; Pui CH; Kitchingman G; Williams D; Melvin S; Murphy SB; Stass S
    Blood; 1985 Nov; 66(5):1115-23. PubMed ID: 3931724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refinement and precision in the classification of murine lymphomas by genotyping with immunoglobulin and T cell receptor probes.
    Vasmel WL; Radaszkiewicz T; Miltenburg AM; Zijlstra M; Melief CJ
    Leukemia; 1987 Mar; 1(3):155-62. PubMed ID: 2889854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell markers in lymphomas and leukemias.
    Bowman WP; Melvin S; Mauer AM
    Adv Intern Med; 1980; 25():391-425. PubMed ID: 6987847
    [No Abstract]   [Full Text] [Related]  

  • 31. [Monoclonal antibodies in the study of leukemia and lymphoma: new classification and prognostic criteria].
    Pagnucco G
    Riv Emoter Immunoematol; 1985; 32(2):227-45. PubMed ID: 2418486
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia.
    Griffin JD; Davis R; Nelson DA; Davey FR; Mayer RJ; Schiffer C; McIntyre OR; Bloomfield CD
    Blood; 1986 Dec; 68(6):1232-41. PubMed ID: 2946331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface markers on leukemia and lymphoma cells: recent advances.
    Foon KA; Schroff RW; Gale RP
    Blood; 1982 Jul; 60(1):1-19. PubMed ID: 6805534
    [No Abstract]   [Full Text] [Related]  

  • 34. The arrangement of immunoglobulin, T cell antigen receptor, and interleukin 2 receptor genes in human lymphoid neoplasms.
    Waldmann TA; Korsmeyer SJ; Greene WC
    Symp Fundam Cancer Res; 1986; 38():63-78. PubMed ID: 3489263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classifying acute leukemia by immunophenotyping: a combined FAB-immunologic classification of AML.
    Neame PB; Soamboonsrup P; Browman GP; Meyer RM; Benger A; Wilson WE; Walker IR; Saeed N; McBride JA
    Blood; 1986 Dec; 68(6):1355-62. PubMed ID: 3465377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell surface markers in hematologic malignancies.
    Freedman AS; Nadler LM
    Semin Oncol; 1987 Jun; 14(2):193-212. PubMed ID: 3296201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical and immunologic diagnosis of cancer. Leukemia and lymphoma.
    Shiku H
    Tumour Biol; 1987; 8(2-3):156-60. PubMed ID: 3329399
    [No Abstract]   [Full Text] [Related]  

  • 38. [Analysis and classification of leukemia and malignant lymphoma cells using monoclonal antibodies].
    Uede T; Kikuchi K
    Nihon Rinsho; 1983; 41(4):815-20. PubMed ID: 6350650
    [No Abstract]   [Full Text] [Related]  

  • 39. The human T-cell leukemias: clinical, cytomorphologic, immunophenotypic, and genotypic characteristics.
    Knowles DM
    Hum Pathol; 1986 Jan; 17(1):14-33. PubMed ID: 3002948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non T lymphoid cells can express T cell surface characteristics: normal, HCL, and a range of leukemic B cells express T cell antigens after appropriate in vitro stimulation.
    Worman CP; Mills KH; Cawley JC
    Semin Oncol; 1984 Dec; 11(4):401-4. PubMed ID: 6334367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.